应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02137 腾盛博药-B
交易中 07-29 15:59:16
2.050
+0.000
0.00%
最高
2.080
最低
1.970
成交量
686.75万
今开
2.050
昨收
2.050
日振幅
5.37%
总市值
14.74亿
流通市值
14.74亿
总股本
7.19亿
成交额
1,391万
换手率
0.96%
流通股本
7.19亿
市净率
0.51
ROE
-18.05%
每股收益
-0.76
52周最高
3.090
52周最低
0.800
市盈率
-2.69
股息
0.00
股息收益率
0.00
ROA
-8.55%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
腾盛博药-B07月28日主力净流入31.8万元 散户资金抛售
市场透视 · 07-28 08:15
腾盛博药-B07月28日主力净流入31.8万元 散户资金抛售
腾盛博药-B07月24日主力净流入169.8万元 散户资金抛售
市场透视 · 07-24
腾盛博药-B07月24日主力净流入169.8万元 散户资金抛售
腾盛博药-B07月18日主力净流出0.1万元 散户资金买入
市场透视 · 07-18
腾盛博药-B07月18日主力净流出0.1万元 散户资金买入
港股异动 | 腾盛博药-B(02137)再涨超8% 近期向健康元集团授予新药BRII-693大中华区独家许可
智通财经 · 07-17
港股异动 | 腾盛博药-B(02137)再涨超8% 近期向健康元集团授予新药BRII-693大中华区独家许可
腾盛博药-B07月16日主力净流入24.5万元 散户资金抛售
市场透视 · 07-16
腾盛博药-B07月16日主力净流入24.5万元 散户资金抛售
腾盛博药-B盘中异动 快速拉升5.41%报1.950港元
市场透视 · 07-15
腾盛博药-B盘中异动 快速拉升5.41%报1.950港元
腾盛博药-B07月11日获主力加仓305.8万元
市场透视 · 07-11
腾盛博药-B07月11日获主力加仓305.8万元
腾盛博药-B盘中异动 早盘大幅拉升5.29%报1.790港元
市场透视 · 07-10
腾盛博药-B盘中异动 早盘大幅拉升5.29%报1.790港元
腾盛博药-B07月08日主力净流出69.0万元 散户资金买入
市场透视 · 07-08
腾盛博药-B07月08日主力净流出69.0万元 散户资金买入
新里程董事长被实施留置;腾盛博药与健康元就在研药达成许可协议 | 医药早参
每日经济新闻 · 07-06
新里程董事长被实施留置;腾盛博药与健康元就在研药达成许可协议 | 医药早参
腾盛博药-B(02137)与健康元集团签署知识产权许可及技术转移协议
智通财经 · 07-04
腾盛博药-B(02137)与健康元集团签署知识产权许可及技术转移协议
腾盛博药-B07月03日遭主力抛售59.4万元
市场透视 · 07-03
腾盛博药-B07月03日遭主力抛售59.4万元
腾盛博药-B07月02日主力净流出104.5万元 散户资金买入
市场透视 · 07-02
腾盛博药-B07月02日主力净流出104.5万元 散户资金买入
腾盛博药-B06月27日遭主力抛售158.3万元
市场透视 · 06-27
腾盛博药-B06月27日遭主力抛售158.3万元
腾盛博药-B盘中异动 早盘急速跳水5.06%报1.690港元
市场透视 · 06-26
腾盛博药-B盘中异动 早盘急速跳水5.06%报1.690港元
腾盛博药-B盘中异动 快速上涨5.33%
市场透视 · 06-24
腾盛博药-B盘中异动 快速上涨5.33%
腾盛博药-B盘中异动 早盘股价大跌5.43%报1.740港元
市场透视 · 06-19
腾盛博药-B盘中异动 早盘股价大跌5.43%报1.740港元
腾盛博药-B盘中异动 早盘急速跳水5.05%
市场透视 · 06-17
腾盛博药-B盘中异动 早盘急速跳水5.05%
港股异动丨生物医药“B类股”全面强势,堃博医疗涨超18%
老虎资讯综合 · 06-12
港股异动丨生物医药“B类股”全面强势,堃博医疗涨超18%
腾盛博药-B盘中异动 早盘股价大涨5.13%
市场透视 · 06-12
腾盛博药-B盘中异动 早盘股价大涨5.13%
加载更多
公司概况
公司名称:
腾盛博药-B
所属市场:
SEHK
上市日期:
2021-07-13
主营业务:
腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。该公司的HBV产品组合包括专有的治疗性疫苗BRII-179、the siRNA BRII-835 (elebsiran),及中和抗体BRII-877 (tobevibart). 该公司拥有多种创新候选药物的产品线,专注于治疗传染病和中枢神经系统疾病。该公司的产品应用于传染病(如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染)及其他疾病(如中枢神经系统(CNS)疾病)。该公司主要在中国国内市场开展业务。
发行价格:
22.250
{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":2.05,"timestamp":1753775928404,"preClose":2.05,"halted":0,"volume":6867500,"delay":0,"floatShares":719000000,"shares":719000000,"eps":-0.760827486541224,"marketStatus":"交易中","change":0,"latestTime":"07-29 15:59:14","open":2.05,"high":2.08,"low":1.97,"amount":13905350,"amplitude":0.053659,"askPrice":2.06,"askSize":112500,"bidPrice":2.05,"bidSize":250000,"shortable":0,"etf":0,"ttmEps":-0.760827486541224,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753776600000},"marketStatusCode":2,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":2.05,"openAndCloseTimeList":[[1753752600000,1753761600000],[1753765200000,1753776000000]],"volumeRatio":0.845148,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"2554758507","title":"腾盛博药-B07月28日主力净流入31.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2554758507","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554758507?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:15","pubTimestamp":1753690532,"startTime":"0","endTime":"0","summary":"07月28日, 腾盛博药-B股价涨3.02%,报收2.05元,成交金额1083.8万元,换手率0.75%,振幅5.53%,量比0.56。腾盛博药-B今日主力资金净流入31.8万元,上一交易日主力净流出84.8万元。该股近5个交易日下跌3.77%,主力资金累计净流入24.6万元;近20日主力资金累计净流入630.2万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165201a4675f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165201a4675f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1161","BK1574","BK1587"],"gpt_icon":0},{"id":"2553207914","title":"腾盛博药-B07月24日主力净流入169.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553207914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553207914?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344952,"startTime":"0","endTime":"0","summary":"07月24日, 腾盛博药-B股价涨4.12%,报收2.02元,成交金额1436.5万元,换手率1.01%,振幅4.64%,量比0.62。腾盛博药-B今日主力资金净流入169.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌4.29%,主力资金累计净流入333.8万元;近20日主力资金累计净流入459.5万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170124a6bf5299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170124a6bf5299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1574","02137"],"gpt_icon":0},{"id":"2552499816","title":"腾盛博药-B07月18日主力净流出0.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2552499816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552499816?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:15","pubTimestamp":1752826547,"startTime":"0","endTime":"0","summary":"07月18日, 腾盛博药-B股价跌2.86%,报收2.04元,成交金额1493.3万元,换手率1.00%,振幅4.29%,量比1.18。腾盛博药-B今日主力资金净流出0.1万元,上一交易日主力净流入177.4万元。该股近5个交易日上涨13.19%,主力资金累计净流入136.8万元;近20日主力资金累计净流入180.8万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718172125a6b1ca7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718172125a6b1ca7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1587","02137"],"gpt_icon":0},{"id":"2552172451","title":"港股异动 | 腾盛博药-B(02137)再涨超8% 近期向健康元集团授予新药BRII-693大中华区独家许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2552172451","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552172451?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:40","pubTimestamp":1752720051,"startTime":"0","endTime":"0","summary":"消息面上,腾盛博药此前宣布,旗下全资子公司腾盛博药美国与健康元集团签订知识产权许可及技术转移协议,授予健康元集团在中国大陆、香港、澳门和台湾等大中华地区,研究、开发和商业化新药BRII-693的独占许可。根据协议,健康元将全面负责BRII-693在大中华区的开发、监管审批和商业化。腾盛博药美国已收取首付款,未来在达成相关里程碑事件时,将收到额外的开发和商业化里程碑付款,并将根据BRII-693的产品净销售额按约定比例获得销售分成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","600380","BK0188","BK0046","BK1574","BK1587","BK0028","BK0077","BK0114","BK0239","02137"],"gpt_icon":0},{"id":"2551382121","title":"腾盛博药-B07月16日主力净流入24.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2551382121","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551382121?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:15","pubTimestamp":1752653754,"startTime":"0","endTime":"0","summary":"07月16日, 腾盛博药-B股价涨1.04%,报收1.95元,成交金额564.2万元,换手率0.41%,振幅4.66%,量比0.81。腾盛博药-B今日主力资金净流入24.5万元,上一交易日主力净流出60.6万元。该股近5个交易日上涨14.71%,主力资金累计净流入404.9万元;近20日主力资金累计净流出70.3万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170911a44e5620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170911a44e5620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"gpt_icon":0},{"id":"2551156800","title":"腾盛博药-B盘中异动 快速拉升5.41%报1.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551156800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551156800?lang=zh_cn&edition=full","pubTime":"2025-07-15 13:56","pubTimestamp":1752558972,"startTime":"0","endTime":"0","summary":"2025年07月15日下午盘13时56分,腾盛博药-B股票出现波动,股价快速上涨5.41%。截至发稿,该股报1.950港元/股,成交量349.3万股,换手率0.49%,振幅6.49%。资金方面,该股资金流入352.173万港元,流出252.794万港元。腾盛博药-B股票所在的生物技术行业中,整体涨幅为3.58%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715135612a44b849d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715135612a44b849d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1587","02137"],"gpt_icon":0},{"id":"2550365519","title":"腾盛博药-B07月11日获主力加仓305.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550365519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550365519?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:15","pubTimestamp":1752221748,"startTime":"0","endTime":"0","summary":"07月11日, 腾盛博药-B股价涨2.25%,报收1.82元,成交金额701.6万元,换手率0.54%,振幅3.93%,量比1.41。腾盛博药-B今日主力资金净流入305.8万元,上一交易日主力净流入139.5万元。该股近5个交易日上涨5.26%,主力资金累计净流入376.3万元;近20日主力资金累计净流出93.8万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711170508a4447258&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711170508a4447258&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02137","BK1587"],"gpt_icon":0},{"id":"2550967926","title":"腾盛博药-B盘中异动 早盘大幅拉升5.29%报1.790港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550967926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550967926?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:18","pubTimestamp":1752117480,"startTime":"0","endTime":"0","summary":"2025年07月10日早盘11时18分,腾盛博药-B股票出现波动,股价急速拉升5.29%。截至发稿,该股报1.790港元/股,成交量236.85万股,换手率0.33%,振幅4.12%。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.17%。腾盛博药与健康元达成BD许可协议。7月4日,腾盛博药宣布已与健康元药业集团就BRII-693达成协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710111800a6a0a1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710111800a6a0a1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02137","BK1574","BK1161"],"gpt_icon":0},{"id":"2549512949","title":"腾盛博药-B07月08日主力净流出69.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2549512949","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549512949?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:15","pubTimestamp":1751962522,"startTime":"0","endTime":"0","summary":"07月08日, 腾盛博药-B股价跌2.86%,报收1.70元,成交金额419.6万元,换手率0.34%,振幅4.57%,量比1.02。腾盛博药-B今日主力资金净流出69.0万元,上一交易日主力净流出0万元。该股近5个交易日上涨0.59%,主力资金累计净流出232.9万元;近20日主力资金累计净流出145.3万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708165006a69cc4c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708165006a69cc4c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","02137"],"gpt_icon":0},{"id":"2549710793","title":"新里程董事长被实施留置;腾盛博药与健康元就在研药达成许可协议 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2549710793","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549710793?lang=zh_cn&edition=full","pubTime":"2025-07-07 07:20","pubTimestamp":1751844023,"startTime":"0","endTime":"0","summary":"丨2025年7月7日星期一丨NO.1新里程董事长林杨林被实施留置并立案调查7月6日,新里程发布公告,称公司收到董事长林杨林家属的通知,林杨林被太原市小店区监察委员会实施留置并立案调查。公司确认董事长林杨林近期无法履职,所涉事项与公司无关。截至公告日,公司未被要求协助调查,也尚未知悉该事项的进展及明确结论。点评:该事件可能对公司投资者的信心产生冲击。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507073449352751.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507073449352751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","02137","BK1574","BK1587","BK1515","BK1161"],"gpt_icon":0},{"id":"2548360533","title":"腾盛博药-B(02137)与健康元集团签署知识产权许可及技术转移协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2548360533","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548360533?lang=zh_cn&edition=full","pubTime":"2025-07-04 08:33","pubTimestamp":1751589201,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B 发布公告,公司全资子公司Brii Biosciences, Inc.已与健康元药业集团股份有限公司签署知识产权许可及技术转移协议。根据本协议约定,健康元集团将全面负责BRII-693在大中华区的开发、监管审批和商业化。作为交易对价,腾盛博药美国已收到首付款,后续在达成相关里程碑事件时将收到额外的开发和商业化里程碑付款,并将根据BRII-693的产品净销售额按约定比例获得销售分成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600380","BK0114","BK0077","BK0046","02137","BK1587","BK0028","BK1574","BK0239","BK1161","BK0188"],"gpt_icon":0},{"id":"2548551803","title":"腾盛博药-B07月03日遭主力抛售59.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548551803","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548551803?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530548,"startTime":"0","endTime":"0","summary":"07月03日, 腾盛博药-B股价跌1.20%,报收1.65元,成交金额520.1万元,换手率0.43%,振幅4.19%,量比1.18。腾盛博药-B今日主力资金净流出59.4万元,上一交易日主力净流出104.5万元。该股近5个交易日下跌7.30%,主力资金累计净流出387.5万元;近20日主力资金累计净流出50.9万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170634a4ccfdd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170634a4ccfdd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02137","BK1161"],"gpt_icon":0},{"id":"2548604768","title":"腾盛博药-B07月02日主力净流出104.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2548604768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548604768?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:15","pubTimestamp":1751444133,"startTime":"0","endTime":"0","summary":"07月02日, 腾盛博药-B股价跌1.18%,报收1.67元,成交金额519.6万元,换手率0.43%,振幅7.10%,量比1.03。腾盛博药-B今日主力资金净流出104.5万元,上一交易日主力净流出0万元。该股近5个交易日下跌5.65%,主力资金累计净流出352.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入54.1万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702170418a72a3e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702170418a72a3e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02137","BK1161"],"gpt_icon":0},{"id":"2546584719","title":"腾盛博药-B06月27日遭主力抛售158.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546584719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546584719?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:15","pubTimestamp":1751012140,"startTime":"0","endTime":"0","summary":"06月27日, 腾盛博药-B股价跌2.91%,报收1.67元,成交金额628.9万元,换手率0.52%,振幅3.49%,量比1.16。腾盛博药-B今日主力资金净流出158.3万元,连续3日净流出,上一交易日主力净流出65.4万元。该股近5个交易日下跌1.17%,主力资金累计净流出168.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入229.9万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172856a7208b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172856a7208b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","02137","BK1161"],"gpt_icon":0},{"id":"2546273197","title":"腾盛博药-B盘中异动 早盘急速跳水5.06%报1.690港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546273197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546273197?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:43","pubTimestamp":1750902233,"startTime":"0","endTime":"0","summary":"2025年06月26日早盘09时43分,腾盛博药-B股票出现波动,股价快速下挫5.06%。截至发稿,该股报1.690港元/股,成交量37.05万股,换手率0.05%,振幅2.81%。资金方面,该股资金流入0港元,流出59.2045万港元。腾盛博药-B股票所在的生物技术行业中,整体跌幅为0.63%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094353a71df490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094353a71df490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","02137"],"gpt_icon":0},{"id":"2545440865","title":"腾盛博药-B盘中异动 快速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545440865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545440865?lang=zh_cn&edition=full","pubTime":"2025-06-24 15:01","pubTimestamp":1750748466,"startTime":"0","endTime":"0","summary":"2025年06月24日下午盘15时01分,腾盛博药-B股票出现波动,股价快速上涨5.33%。截至发稿,该股报1.780港元/股,成交量380.3万股,换手率0.53%,振幅5.33%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。腾盛博药-B股票所在的生物技术行业中,整体涨幅为1.88%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624150106a4baf212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624150106a4baf212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","02137"],"gpt_icon":0},{"id":"2544135975","title":"腾盛博药-B盘中异动 早盘股价大跌5.43%报1.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544135975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544135975?lang=zh_cn&edition=full","pubTime":"2025-06-19 11:06","pubTimestamp":1750302397,"startTime":"0","endTime":"0","summary":"2025年06月19日早盘11时06分,腾盛博药-B股票出现异动,股价急速下挫5.43%。截至发稿,该股报1.740港元/股,成交量181.1万股,换手率0.25%,振幅5.98%。资金方面,该股资金流入51.461万港元,流出260.763万港元。腾盛博药-B股票所在的生物技术行业中,整体跌幅为2.56%。其相关个股中,帝王国际投资、云康集团、科济药业-B涨幅较大,振幅较大的相关个股有帝王国际投资、云康集团、中国抗体-B,振幅分别为16.50%、10.61%、10.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619110637a711a767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619110637a711a767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02137","BK1587"],"gpt_icon":0},{"id":"2544812935","title":"腾盛博药-B盘中异动 早盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544812935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544812935?lang=zh_cn&edition=full","pubTime":"2025-06-17 10:30","pubTimestamp":1750127422,"startTime":"0","endTime":"0","summary":"2025年06月17日早盘10时30分,腾盛博药-B股票出现异动,股价快速下挫5.05%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。腾盛博药-B股票所在的生物技术行业中,整体跌幅为1.70%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617103022a4ad4c60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617103022a4ad4c60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02137"],"gpt_icon":0},{"id":"1140632215","title":"港股异动丨生物医药“B类股”全面强势,堃博医疗涨超18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140632215","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140632215?lang=zh_cn&edition=full","pubTime":"2025-06-12 13:34","pubTimestamp":1749706496,"startTime":"0","endTime":"0","summary":"腾盛博药涨超14%","market":"hk","thumbnail":"https://static.tigerbbs.com/60dc0571033d09242f5df57af9eee765","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/60dc0571033d09242f5df57af9eee765"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02216","02137"],"gpt_icon":0},{"id":"2542552434","title":"腾盛博药-B盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542552434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542552434?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:41","pubTimestamp":1749692491,"startTime":"0","endTime":"0","summary":"2025年06月12日早盘09时41分,腾盛博药-B股票出现波动,股价快速上涨5.13%。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,再鼎医药、思路迪医药股份、腾盛博药-B涨幅较大,振幅较大的相关个股有北海康成-B、来凯医药-B、博安生物,振幅分别为9.88%、9.03%、8.16%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506120941319518afee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506120941319518afee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","02137"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":0.2275},{"period":"3month","weight":0.0513},{"period":"6month","weight":0.8304},{"period":"1year","weight":0.9712},{"period":"ytd","weight":1.0918}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.2639},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.2743}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。该公司的HBV产品组合包括专有的治疗性疫苗BRII-179、the siRNA BRII-835 (elebsiran),及中和抗体BRII-877 (tobevibart). 该公司拥有多种创新候选药物的产品线,专注于治疗传染病和中枢神经系统疾病。该公司的产品应用于传染病(如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染)及其他疾病(如中枢神经系统(CNS)疾病)。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.068599},{"month":2,"riseRate":0.5,"avgChangeRate":0.053469},{"month":3,"riseRate":0.25,"avgChangeRate":-0.171794},{"month":4,"riseRate":0.25,"avgChangeRate":-0.017909},{"month":5,"riseRate":0,"avgChangeRate":-0.064507},{"month":6,"riseRate":0.25,"avgChangeRate":-0.093488},{"month":7,"riseRate":1,"avgChangeRate":0.103075},{"month":8,"riseRate":0.25,"avgChangeRate":0.023974},{"month":9,"riseRate":0.5,"avgChangeRate":-0.020754},{"month":10,"riseRate":0.25,"avgChangeRate":-0.137315},{"month":11,"riseRate":0.75,"avgChangeRate":0.36887},{"month":12,"riseRate":0.25,"avgChangeRate":-0.145576}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}